---

$3.90

+0.2050 ( +4.99% ) 113.0K

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-15	Buy	10000.00	ALTSCHULLER Susan
2024-07-31	Sale	-15334.00	Golumbeski George
2024-07-18	Sale	-2157.00	Keson-Brookes Maiken
2024-07-08	Sale	-12531.00	Loew Caroline
2024-06-03	Sale	-8462.00	Jackson Scott Thomas
2024-06-03	Sale	-8462.00	Hickey Benjamin
2024-06-03	Sale	-8462.00	Cuss Francis M
2024-06-03	Sale	-8462.00	ALTSCHULLER Susan
2024-03-04	Sale	-16800.00	Keson-Brookes Maiken
2024-03-04	Sale	-48475.00	Loew Caroline

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.